Diagnostics technology provider Sofie has completed a $27.4m series C round led by $25m from Jubilant Radiopharma at a $100m valuation.

Mental health support service Koa Health has spun off and reached the $16.5m first close for a series A round co-led by Ancora Finance Group and Wellington Partners.

Tampa General Hospital will begin a diversified corporate venturing programme when Rachel Feinman joins it in early 2021.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Takeda Ventures and Chiesi Ventures are set to exit the cancer drug developer through the deal, which came after just over $200m in funding.

WuXi AppTec and Juno Therapeutics' joint cancer immunotherapy venture has listed on the Hong Kong Stock Exchange.

Venture firm Seventure’s Health For Life Capital Fund II has received a contribution of undisclosed size from Archer Daniels Midland.

Sana Biotechnology has bought central nervous system therapy developer and portfolio company Oscine, which is founded on University of Rochester research.

Hans Lenk and Gustavo Cavenaghi have launched Kortex Ventures, which will invest up to $35m on behalf of two large healthcare corporations in Brazil.

The University of Aberdeen bone grafting spinout has been acquired after raising more than $4.8m from investors including Armourers and Brasiers.